Masimo (MASI) Other Accumulated Expenses (2021 - 2022)
Masimo's (MASI) quarterly Other Accumulated Expenses came in at $183.3 million in Q4 2022, up 160.37% year-on-year from $70.4 million in Q4 2021, and up 160.37% quarter-over-quarter from $70.4 million in Q1 2022.
Masimo (MASI) Other Accumulated Expenses (2021 - 2022) Analysis & Trends
Masimo's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $183.3 million for Q4 2022.
- On a quarterly basis, Other Accumulated Expenses rose 160.37% year-over-year to $183.3 million in Q4 2022; TTM through Dec 2022 was $183.3 million, a 160.37% increase from a year earlier, with the FY2022 full-year figure at $183.3 million, up 160.37% from the prior year.
- Other Accumulated Expenses rose to $183.3 million in Q4 2022 per MASI's latest filing, from $70.4 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $183.3 million in Q4 2022 and bottomed at $53.2 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 183.30 Mn |
| Jan 1, 2022 | 70.40 Mn |
| Jan 2, 2021 | 53.24 Mn |